Discover and read the best of Twitter Threads about #InformedDecision
Most recents (2)
⚠ #TRIGGERWARNING #ABA ⚠
I am raising my head above the parapet and posting about something which causes me great concern on many fronts, as a:
🧠#neurodivergent individual
👩🎓#Neurodiversity-advocating Professional
👩👧👦Mother of 2 neurodivergent #children living in Leicestershire
I am raising my head above the parapet and posting about something which causes me great concern on many fronts, as a:
🧠#neurodivergent individual
👩🎓#Neurodiversity-advocating Professional
👩👧👦Mother of 2 neurodivergent #children living in Leicestershire
It seems that, for a number of years, the LA has been at the forefront of an initiative to find: "Cost-effective models for delivering behaviour analysis teaching in UK schools and local authorities"
LINK: lnkd.in/eGbMBCm7
LINK: lnkd.in/eGbMBCm7
Integrating ABA into #maintained & #academy, #mainstream & #SpecialSchool for "affordable" "positive outcomes". It concludes, "School-based models, such as Leicestershire's, provide a sustainable model which can be used with a large number of children for...little extra cost."
@TumorBoardTues @PGrivasMDPhD @MPishvaian @JohnEbbenMDPhD 1/19 #TumorBoardTuesday #BladderCancer #OncTwitter
74 yo🧓🏼
HTN
DM2
2020: localized Rt upper tract urothelial carcinoma
2020: ✂️ radical nephroureterectomy
🧪Germline testing negative
Complicated by CKD stage 4 after ✂️ (creatinine clearance 25 ml/min)
🩻Restaging CT CAP 1 year
74 yo🧓🏼
HTN
DM2
2020: localized Rt upper tract urothelial carcinoma
2020: ✂️ radical nephroureterectomy
🧪Germline testing negative
Complicated by CKD stage 4 after ✂️ (creatinine clearance 25 ml/min)
🩻Restaging CT CAP 1 year
@TumorBoardTues @PGrivasMDPhD @MPishvaian @JohnEbbenMDPhD 🩻 NEW metastatic disease to spine, 🫁 and retroperitoneal lymph nodes
ECOG PS 2
🔬Biopsy of RP lymph node: Metastatic #UrothelialCarcinoma
🧪Molecular: FGFR3-TACC3 fusion, MTAP loss, CDKN2A loss
🤨 What 1L treatment would you pick for this patient?
ECOG PS 2
🔬Biopsy of RP lymph node: Metastatic #UrothelialCarcinoma
🧪Molecular: FGFR3-TACC3 fusion, MTAP loss, CDKN2A loss
🤨 What 1L treatment would you pick for this patient?
@TumorBoardTues @PGrivasMDPhD @MPishvaian @JohnEbbenMDPhD 3/19 #TumorBoardTuesday @PGrivasMDPhD @MPishvaian @JohnEbbenMDPhD #UrothelialCancer
🤔 Is the above 74yo 🧓🏼 patient a good candidate for platinum-based chemotherapy?
🤨 Poll: Which of these criteria would make this patient platinum-ineligible?
🤔 Is the above 74yo 🧓🏼 patient a good candidate for platinum-based chemotherapy?
🤨 Poll: Which of these criteria would make this patient platinum-ineligible?
